08.00-09.30     ICC AUDITORIUM   

HLA and non-HLA Antibodies - Avoid them or treat them?

Chairs: Anthony Dorling, London, UK
            Bruno Watschinger, Vienna, Austria

Non-HLA Antibodies - ready to enter the clinic arena?
Magali Giral, Nantes, France
What is the best HLA-desensitisation protocol with regard to long term outcomes?
Ondrej Viklicky, Prague, Czech Republic
Post-transplant DSA – ignore, follow, treat?
Thomas Fehr, Zurich, Switzerland
Kidney exchange and domino-paired transplantation
Willem Weimar, Rotterdam, The Netherlands


back to the timetable